Medtronic nabs 510(k) for combination surgical device

Medtronic ($MDT) has secured the FDA's blessing to market its Aquamantys 3 BSC 9.1S bipolar sealer with cutting, a device that combines two surgical techs in one. Medtronic's instrument features hemostatic sealing capabilities for bone and soft tissue, in addition to blades for cutting. The sealer includes the company's Transcollation technology, using radiofrequency energy and saline to reduce bone loss and keep hemoglobin levels stable, the company said. Release

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.